Search clinical trials for: docetaxel trastuzumab
Total 3208 results
-
Jonsson Comprehensive Cancer CenterCompletedBreast CancerUnited States
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Breast CancerChina
-
European Organisation for Research and Treatment...GlaxoSmithKlineCompletedBreast CancerFrance, United Kingdom, Belgium, Switzerland, Slovenia
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdUnknown
-
Finnish Breast Cancer GroupCompleted
-
Austrian Breast & Colorectal Cancer Study GroupHoffmann-La Roche; CephalonCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHER2-positive Breast Cancer | Early-stage Breast Cancer | Adjuvant Treatment After Trastuzumab | RCB Classification 1-2 | NeratiniChina
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis PharmaceuticalsTerminated
-
Biocon Biologics UK LtdNot yet recruitingHR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Hebei Medical University Fourth HospitalOrigiMedRecruitingProspective | ObservationalChina
-
Cancer Trials IrelandCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
Samsung Bioepis Co., Ltd.CompletedHER2 Positive Early or Locally Advanced Breast CancerCzechia
-
Intergroupe Francophone de Cancerologie ThoraciqueCompletedNon Small Cell Lung Cancer Metastatic | HER2 Gene Mutation | Non Small Cell Lung Cancer Stage IIIFrance
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
Shandong UniversityUnknownHER2-positive Breast Cancer
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Genentech, Inc.Completed
-
PfizerCompleted
-
SanofiCompletedBreast NeoplasmsFrance, Brazil, Poland, Germany, Belgium, Tunisia, United Kingdom, Uruguay
-
Peking University People's HospitalRecruitingHER2-positive Early Breast CancerChina
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
Nanogen Pharmaceutical Biotechnology Joint Stock...Vietstar Biomedical Research; MedProve IncCompletedBreast Cancer Recurrent | Breast Cancer Female | Breast Cancer MetastaticVietnam
-
Jonsson Comprehensive Cancer CenterGenentech, Inc.; Aventis PharmaceuticalsCompleted
-
Danish Breast Cancer Cooperative GroupSanofi; Hoffmann-La RocheUnknown
-
Merrimack PharmaceuticalsCompletedHER-2 Gene AmplificationUnited States
-
Henan Cancer HospitalCompletedHER2 Positive Breast CancerChina
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastUnited States, France, Ireland
-
R-PharmCompletedMetastatic Breast CancerItaly, Turkey, Spain, France, Greece
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Hoffmann-La RocheCompletedBreast CancerAustralia, Spain, United Kingdom, France, Sweden, Canada, Finland, Italy, Greece, Mexico, Costa Rica, Poland, Brazil, Guatemala, Panama
-
Guangdong Provincial People's HospitalCompletedHER2-Positive Breast CancerChina
-
Henan Cancer HospitalRecruitingBreast Cancer,Her2 PositiveChina
-
Gruppo Oncologico Italiano di Ricerca ClinicaMipharm SpA; Temas srl; Clirest s.r.l.; University Hospital of Parma: Department... and other collaboratorsUnknown
-
Xuekui LiuNot yet recruiting
-
Hoffmann-La RocheGenentech, Inc.CompletedBreast CancerUnited States, Italy, United Kingdom, Australia, Austria, Belgium, Brazil, Denmark, France, Guatemala, Korea, Republic of, Portugal, Spain, Turkey, Colombia, Canada, Czechia, Japan, Poland, Romania, Russian Federation, Switzerland, ... and more
-
Incyte CorporationTerminated
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2-PositiveRecurrent or Metastatic Breast Cancer
-
University of MiamiAventis PharmaceuticalsCompletedBreast CancerUnited States
-
PfizerCompletedEarly Breast CancerCzechia, Serbia, Slovakia, United States, Belarus, Hungary, Ukraine, Italy, Poland, Russian Federation
-
Translational Oncology Research InternationalNational Cancer Institute (NCI); University of California, Los AngelesCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Novartis PharmaceuticalsNCIC Clinical Trials GroupCompletedBreast CancerUnited States, Belgium, Canada, United Kingdom, Argentina, Australia, France, Germany, Israel, Italy, Japan, Netherlands, Poland, Russian Federation, Spain, Taiwan, Thailand, India, Korea, Republic of, Mexico, Ukraine
-
Lawson Health Research InstituteThe Ottawa HospitalCompleted
-
Shanghai Henlius BiotechCompletedBreast CancerChina, Ukraine, Philippines